Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis
Tina Rike Herold,1 Veronika Jakl,3 Anno Graser,4 Kirsten Eibl-Lindner1,21Department of Ophthalmology, 2Department of Ophthalmology, Campus Innenstadt, 3Department of Neurology, 4Department of Clinical Radiology, Campus Grosshadern, University of Munich, Ludwig-Maximilians University, Munich, Germany...
Guardado en:
Autores principales: | Herold TR, Jakl V, Graser A, Eibl-Lindner K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bcaa3461541c4252bb46b7feb1a3b513 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The use of natalizumab for multiple sclerosis
por: Brandstadter R, et al.
Publicado: (2017) -
Natalizumab for the treatment of relapsing multiple sclerosis
por: Richard A Rudick, et al.
Publicado: (2008) -
Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding
por: Melissa S. Maginnis, et al.
Publicado: (2013) -
Homonymous hemianopia: challenges and solutions
por: Goodwin D
Publicado: (2014) -
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
por: Carmen Tur, et al.
Publicado: (2013)